@prefix ns1: <http://linked.opendata.cz/ontology/drug-encyclopedia/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<http://linked.opendata.cz/resource/ATC/L01XX11> a ns1:ATCConcept ;
    skos:notation "L01XX11" ;
    skos:prefLabel "Estramustin"@cs,
        "Estramustine"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0007783> a ns1:Ingredient ;
    ns1:contraindicatedWith "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999",
        "http://linked.opendata.cz/resource/ndfrt/disease/N0000002934",
        "http://linked.opendata.cz/resource/ndfrt/disease/N0000002935" ;
    ns1:description "A nitrogen mustard linked to estradiol, usually as phosphate; used to treat prostatic neoplasms; also has radiation protective properties.     "@en ;
    ns1:hasMechanismOfAction "http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000236" ;
    ns1:hasMedicinalProduct "http://linked.opendata.cz/resource/sukl/medicinal-product/ESTRACYT" ;
    ns1:hasPharmacologicalAction "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0028268",
        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0028300" ;
    ns1:hasPhysiologicEffect "http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009002",
        "http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009461" ;
    ns1:mayTreat "http://linked.opendata.cz/resource/ndfrt/disease/N0000002500" ;
    ns1:title "Estramustin"@cs,
        "Estramustine"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0028268> a ns1:PharmacologicalAction ;
    ns1:description "A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026)     "@en ;
    ns1:title "Antitumorózní látky alkylující"@cs,
        "Antineoplastic agents, alkylating"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0028300> a ns1:PharmacologicalAction ;
    ns1:description "Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079)     "@en ;
    ns1:title "Antitumorózní látky hormonální"@cs,
        "Antineoplastic agents, hormonal"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000999> a ns1:DiseaseOrFinding ;
    ns1:description "Immunologically mediated adverse reactions to medicinal substances used legally or illegally.     "@en ;
    ns1:title "Léková alergie"@cs,
        "Drug hypersensitivity"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000002500> a ns1:DiseaseOrFinding ;
    ns1:description "Tumors or cancer of the PROSTATE.     "@en ;
    ns1:title "Prostata - nádory"@cs,
        "Prostatic neoplasms"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000002934> a ns1:DiseaseOrFinding ;
    ns1:description "Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.     "@en ;
    ns1:title "Tromboembolie"@cs,
        "Thromboembolism"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000002935> a ns1:DiseaseOrFinding ;
    ns1:description "Inflammation of a vein associated with a blood clot (THROMBUS).     "@en ;
    ns1:title "Tromboflebitida"@cs,
        "Thrombophlebitis"@en .

<http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000236> a ns1:MechanismOfAction ;
    ns1:title "Alkylating Activity"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009002> a ns1:PhysiologicEffect ;
    ns1:title "Decreased Testosterone Secretion"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009461> a ns1:PhysiologicEffect ;
    ns1:title "Increased Ovarian Estrogen Secretion"@en .

<http://linked.opendata.cz/resource/sukl/medicinal-product/ESTRACYT> a ns1:MedicinalProduct ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/L01XX11" ;
    ns1:title "ESTRACYT"@cs .


